Need help finding what you are looking for?
Contact Us
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1075644
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1075644
Global mRNA Vaccines & Therapeutics Market Size study, by mRNA Type (Nucleoside-Modified mRNA, Unmodified mRNA and Self-Amplifying mRNA), by Application, by End-user, and Regional Forecasts 2022-2028
PUBLISHED:
PAGES:
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Contact us about how to customize the report with add-on data.
Global mRNA Vaccines & Therapeutics Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 16.8% over the forecast period 2022-2028. Messenger Ribonucleic Acid (mRNA) is a single protein-coding gene found in the genome that serves as the foundation for protein synthesis in cells. mRNA vaccines and treatments are made in labs utilizing mammalian cells and have favorable immunological characteristics. non-replicating, in vivo self-replicating, Self-amplifying, and in vitro dendritic cell non-replicating mRNA are some of the most frequent forms of vaccines and treatments. They are injected into the body to activate virus-detecting immunological sensors and cause the cells to generate viral antigen proteins. By increasing B- and T-cell responses contribute to improving the body's immunity. The market growth is driven by key factors such as rise in prevalence of cancer and increase in awareness about vaccination. According to Statista, Breast cancer was the most common cancer form in 2020, with roughly 48 women diagnosed per 100,000 people. Prostate cancer had a 12-month prevalence rate of 30.4 per 100,000 people at the time. However, growing demand for therapeutic medicines impedes the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global mRNA Vaccines & Therapeutics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. in which, North America is leading the market share and is expected to be the fastest growing region in the forecast years. Factors supporting the market growth are the plentiful presence of prominent players & exponentially surging number of COVID-19 patients in the US.
Major market players included in this report are:
- Arcturus Therapeutics Holdings Inc.
- Providence Therapeutics
- CureVac N.V.
- GlaxoSmithKline plc
- Pantherna Therapeutics GmbH
- Silence Therapeutics
- Ethris GmbH
- BioNTech
- Versameb AG
- Gennova Biopharmaceuticals Ltd
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and mRNA Type offerings of key players. The detailed segments and sub-segment of the market are explained below:
By mRNA Type:
- Nucleoside-Modified mRNA (modRNA)
- Unmodified mRNA
- Self-Amplifying mRNA
By Application:
- COVID mRNA Application
- Non-COVID mRNA Application
By End-User:
- Hospitals & healthcare Clinics
- Research Organisation & Institutions
- Others
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- Rest of the World
Furthermore, years considered for the study are as follows:
- Historical year - 2018, 2019, 2020
- Base year - 2021
- Forecast period - 2022 to 2028
Target Audience of the Global mRNA vaccines & therapeutics Market in Market Study:
- Key Consulting Companies & Advisors
- Large, medium-sized, and small enterprises
- Venture capitalists
- Value-Added Resellers (VARs)
- Third-party knowledge providers
- Investment bankers
- Investors
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
- 1.2.1. mRNA Vaccines and Therapeutics Market, by Region, 2020-2028 (USD Billion)
- 1.2.2. mRNA Vaccines and Therapeutics Market, by MRNA Type, 2020-2028 (USD Billion)
- 1.2.3. mRNA Vaccines and Therapeutics Market, by Application, 2020-2028 (USD Billion)
- 1.2.4. mRNA Vaccines and Therapeutics Market, by End-User, 2020-2028 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global mRNA Vaccines and Therapeutics Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global mRNA Vaccines and Therapeutics Market Dynamics
- 3.1. mRNA Vaccines and Therapeutics Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
- 3.1.1.1. Rise in prevalence of cancer
- 3.1.1.2. Increase in awareness about vaccination
- 3.1.2. Market Challenges
- 3.1.2.1. Growing demand for therapeutic medicines
- 3.1.3. Market Opportunities
- 3.1.3.1. Developments in the lipid nanoparticle formulations for in-vivo systemic delivery of mRNA
- 3.1.1. Market Drivers
Chapter 4. Global mRNA Vaccines and Therapeutics Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
- 4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.3. Investment Adoption Model
- 4.4. Analyst Recommendation & Conclusion
- 4.5. Top investment opportunity
- 4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1.1. Assessment of the overall impact of COVID-19 on the industry
- 5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global mRNA Vaccines and Therapeutics Market, by MRNA Type
- 6.1. Market Snapshot
- 6.2. Global mRNA Vaccines and Therapeutics Market by mRNA Type, Performance - Potential Analysis
- 6.3. Global mRNA Vaccines and Therapeutics Market Estimates & Forecasts by mRNA Type, 2018-2028 (USD Billion)
- 6.4. mRNA Vaccines and Therapeutics Market, Sub Segment Analysis
- 6.4.1. Nucleoside-Modified mRNA (modRNA)
- 6.4.2. Unmodified mRNA
- 6.4.3. Self-Amplifying mRNA
Chapter 7. Global mRNA Vaccines and Therapeutics Market, by Application
- 7.1. Market Snapshot
- 7.2. Global mRNA Vaccines and Therapeutics Market by Application, Performance - Potential Analysis
- 7.3. Global mRNA Vaccines and Therapeutics Market Estimates & Forecasts by Application, 2018-2028 (USD Billion)
- 7.4. mRNA Vaccines and Therapeutics Market, Sub Segment Analysis
- 7.4.1. COVID mRNA Application
- 7.4.2. Non-COVID mRNA Application
Chapter 8. Global mRNA Vaccines and Therapeutics Market, by End-User
- 8.1. Market Snapshot
- 8.2. Global mRNA Vaccines and Therapeutics Market by End-User, Performance - Potential Analysis
- 8.3. Global mRNA Vaccines and Therapeutics Market Estimates & Forecasts by End-User, 2018-2028 (USD Billion)
- 8.4. mRNA Vaccines and Therapeutics Market, Sub Segment Analysis
- 8.4.1. Hospitals & healthcare Clinics
- 8.4.2. Research Organisation & Institutions
- 8.4.3. Others
Chapter 9. Global mRNA Vaccines and Therapeutics Market, Regional Analysis
- 9.1. mRNA Vaccines and Therapeutics Market, Regional Market Snapshot
- 9.2. North America mRNA Vaccines and Therapeutics Market
- 9.2.1. U.S. mRNA Vaccines and Therapeutics Market
- 9.2.1.1. mRNA Type breakdown estimates & forecasts, 2018-2028
- 9.2.1.2. Application breakdown estimates & forecasts, 2018-2028
- 9.2.1.3. End-User breakdown estimates & forecasts, 2018-2028
- 9.2.2. Canada mRNA Vaccines and Therapeutics Market
- 9.2.1. U.S. mRNA Vaccines and Therapeutics Market
- 9.3. Europe mRNA Vaccines and Therapeutics Market Snapshot
- 9.3.1. U.K. mRNA Vaccines and Therapeutics Market
- 9.3.2. Germany mRNA Vaccines and Therapeutics Market
- 9.3.3. France mRNA Vaccines and Therapeutics Market
- 9.3.4. Spain mRNA Vaccines and Therapeutics Market
- 9.3.5. Italy mRNA Vaccines and Therapeutics Market
- 9.3.6. Rest of Europe mRNA Vaccines and Therapeutics Market
- 9.4. Asia-Pacific mRNA Vaccines and Therapeutics Market Snapshot
- 9.4.1. China mRNA Vaccines and Therapeutics Market
- 9.4.2. India mRNA Vaccines and Therapeutics Market
- 9.4.3. Japan mRNA Vaccines and Therapeutics Market
- 9.4.4. Australia mRNA Vaccines and Therapeutics Market
- 9.4.5. South Korea mRNA Vaccines and Therapeutics Market
- 9.4.6. Rest of Asia Pacific mRNA Vaccines and Therapeutics Market
- 9.5. Latin America mRNA Vaccines and Therapeutics Market Snapshot
- 9.5.1. Brazil mRNA Vaccines and Therapeutics Market
- 9.5.2. Mexico mRNA Vaccines and Therapeutics Market
- 9.6. Rest of The World mRNA Vaccines and Therapeutics Market
Chapter 10. Competitive Intelligence
- 10.1. Top Market Strategies
- 10.2. Company Profiles
- 10.2.1. Gennova Biopharmaceuticals Ltd
- 10.2.1.1. Key Information
- 10.2.1.2. Overview
- 10.2.1.3. Financial (Subject to Data Availability)
- 10.2.1.4. ProductSummary
- 10.2.1.5. Recent Developments
- 10.2.2. Arcturus Therapeutics Holdings Inc.
- 10.2.3. Providence Therapeutics
- 10.2.4. CureVac N.V.
- 10.2.5. GlaxoSmithKline plc
- 10.2.6. Pantherna Therapeutics GmbH
- 10.2.7. Silence Therapeutics
- 10.2.8. Ethris GmbH
- 10.2.9. BioNTech
- 10.2.10. Versameb AG
- 10.2.1. Gennova Biopharmaceuticals Ltd
Chapter 11. Research Process
- 11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
- 11.2. Research Attributes
- 11.3. Research Assumption
LIST OF TABLES
- TABLE 1. Global mRNA Vaccines and Therapeutics market, report scope
- TABLE 2. Global mRNA Vaccines and Therapeutics market estimates & forecasts by Region 2018-2028 (USD Billion)
- TABLE 3. Global mRNA Vaccines and Therapeutics market estimates & forecasts by mRNA Type 2018-2028 (USD Billion)
- TABLE 4. Global mRNA Vaccines and Therapeutics market estimates & forecasts by Application 2018-2028 (USD Billion)
- TABLE 5. Global mRNA Vaccines and Therapeutics market estimates & forecasts by End User 2018-2028 (USD Billion)
- TABLE 6. Global mRNA Vaccines and Therapeutics market by segment, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 7. Global mRNA Vaccines and Therapeutics market by region, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 8. Global mRNA Vaccines and Therapeutics market by segment, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 9. Global mRNA Vaccines and Therapeutics market by region, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 10. Global mRNA Vaccines and Therapeutics market by segment, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 11. Global mRNA Vaccines and Therapeutics market by region, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 12. Global mRNA Vaccines and Therapeutics market by segment, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 13. Global mRNA Vaccines and Therapeutics market by region, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 14. Global mRNA Vaccines and Therapeutics market by segment, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 15. Global mRNA Vaccines and Therapeutics market by region, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 16. U.S. mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 17. U.S. mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 18. U.S. mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 19. Canada mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 20. Canada mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 21. Canada mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 22. UK mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 23. UK mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 24. UK mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 25. Germany mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 26. Germany mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 27. Germany mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 28. RoE mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 29. RoE mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 30. RoE mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 31. China mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 32. China mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 33. China mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 34. India mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 35. India mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 36. India mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 37. Japan mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 38. Japan mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 39. Japan mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 40. RoAPAC mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 41. RoAPAC mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 42. RoAPAC mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 43. Brazil mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 44. Brazil mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 45. Brazil mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 46. Mexico mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 47. Mexico mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 48. Mexico mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 49. RoLA mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 50. RoLA mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 51. RoLA mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 52. Row mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 53. Row mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 54. Row mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 55. List of secondary sources, used in the study of global mRNA Vaccines and Therapeutics market
- TABLE 56. List of primary sources, used in the study of global mRNA Vaccines and Therapeutics market
- TABLE 57. Years considered for the study
- TABLE 58. Exchange rates considered
LIST OF FIGURES
List of figures
- FIG 1. Global RNA Vaccines and Therapeutics market, research methodology
- FIG 2. Global mRNA Vaccines and Therapeutics market, market estimation techniques
- FIG 3. Global market size estimates & forecast methods
- FIG 4. Global mRNA Vaccines and Therapeutics market, key trends 2021
- FIG 5. Global mRNA Vaccines and Therapeutics market, growth prospects 2022-2028
- FIG 6. Global mRNA Vaccines and Therapeutics market, porters 5 force model
- FIG 7. Global mRNA Vaccines and Therapeutics market, pest analysis
- FIG 8. Global mRNA Vaccines and Therapeutics market, value chain analysis
- FIG 9. Global mRNA Vaccines and Therapeutics market by segment, 2018 & 2028 (USD Billion)
- FIG 10. Global mRNA Vaccines and Therapeutics market by segment, 2018 & 2028 (USD Billion)
- FIG 11. Global mRNA Vaccines and Therapeutics market by segment, 2018 & 2028 (USD Billion)
- FIG 12. Global mRNA Vaccines and Therapeutics market by segment, 2018 & 2028 (USD Billion)
- FIG 13. Global mRNA Vaccines and Therapeutics market by segment, 2018 & 2028 (USD Billion)
- FIG 14. Global mRNA Vaccines and Therapeutics market, regional snapshot 2018 & 2028
- FIG 15. North America mRNA Vaccines and Therapeutics market 2018 & 2028 (USD Billion)
- FIG 16. Europe mRNA Vaccines and Therapeutics market 2018 & 2028 (USD Billion)
- FIG 17. Asia Pacific mRNA Vaccines and Therapeutics market 2018 & 2028 (USD Billion)
- FIG 18. Latin America mRNA Vaccines and Therapeutics market 2018 & 2028 (USD Billion)
- FIG 19. Global mRNA Vaccines and Therapeutics market, company market share analysis (2021)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.